REG - APQ Global Limited - Publication of Circular & Notice of Meetings

APQ GlobalAnnouncement

06/03/2025 13:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250306:nRSF6883Za&default-theme=true

RNS Number : 6883Z  APQ Global Limited  06 March 2025

APQ Global Limited

("APQ Global" or the "Company")

 

Publication of Circular, Notice of EGM & CULS Meeting

 

APQ Global Limited, a company incorporated in Guernsey, announces that it has
today published a circular ("Circular") to shareholders and holders of 3.5 per
cent. convertible loan stock 2024 (the "CULS") including the notice of
extraordinary general meeting (the "EGM") and notice of a meeting for the
holders of the CULS (the "CULS Meeting") to be held at the Company's
registered office, 2nd Floor, Lefebvre Place, Lefebvre Street, St Peter Port,
Guernsey, GY1 2JP, Channel Islands at 10.30 a.m. and 10.35 a.m.  (or as soon
thereafter as the preceding EGM concludes or is adjourned) respectively on 31
March 2025.

 

APQ Global Limited is seeking:

 

(a)         the approval of shareholders and CULS holders for the
cancellation of admission of the ordinary shares of no par value (the
"Ordinary Shares") to trading on AIM (the "Cancellation"); and

 

(b)         the approval of the CULS holders for amendments to the Trust
Deed constituting the CULS (the "Trust Deed Amendments") to facilitate
Cancellation and for the deferral of the settlement date from 31 March 2025 to
31 December 2025 (the "Deferred Settlement Date"). In consideration of CULS
holders approving the proposed deferral of the full payment of the outstanding
CULS redemption proceeds, the interest rate applying to the outstanding CULS
will be increased from 6.0 per cent. to 10.0 per cent. for the period from 31
March 2025 to 31 December 2025.

 

The Circular and the notice of EGM and CULS Meeting will shortly be available
to view on the Company's website: https://www.apqglobal.com/
(https://www.apqglobal.com/) .

 

Defined terms used in this announcement shall, unless the context otherwise
requires, have the same meanings as set out in the Circular.

 

- End -

 

For further enquiries, please contact:

 

 APQ Global Limited                                     020 3478 9708
 Bart Turtelboom

 Singer Capital Markets - Nominated Adviser and Broker  020 7496 3000
 James Maxwell

 Suntera - TISE sponsor                                 01481 737 279
 Claire Torode

 Investor Relations

 IR@APQGlobal.com

 

Notes to Editors

 

APQ Global Limited

 APQ Global (ticker: APQ LN) is an investment company incorporated in
Guernsey. The Company focuses its investment activities globally (in Asia,
Latin America, Eastern Europe, the Middle East, Africa and the Channel
Islands, particularly). The objective of the Company is to steadily grow its
earnings to seek to deliver attractive returns and capital growth through a
combination of building growing businesses as well as earning revenue from
income generating operating activities in capital markets(1.) APQ Global run
a well-diversified and liquid portfolio, take strategic stakes in selected
businesses and plan to take operational control of companies through the
acquisition of minority and majority stakes in companies with a focus on
emerging markets. For more information, please visit apqglobal.com
(http://www.apqglobal.com/) .

1 Where we refer to revenue from income generating operating activities this
relates to the revenue of our investee companies.

 

LETTER FROM THE CHAIRMAN OF APQ CONTAINED WITHIN THE CIRCULAR

 

1.   Introduction

 

APQ Global Limited is seeking:

 

(a)          the approval of Shareholders and CULS Holders for the
cancellation of admission of the Ordinary Shares to trading on AIM (the
"Cancellation"); and

 

(b)          the approval of holders of the Company's 3.5 per cent.
convertible unsecured loan stock 2024 (the "CULS") for amendments to the Trust
Deed constituting the CULS (the "Trust Deed Amendments").

 

The purpose of the Circular is to convene the Extraordinary General Meeting
and the CULS Meeting at which the Resolutions relating to the Proposals will
be proposed, and to explain why the Board believes the approval of the
Proposals is in the best interests of the Company and for the benefit of the
Shareholders and the CULS Holders.

 

2.   Background to and reasons for the Cancellation of AIM admission

 

Following a prolonged period of weak share price performance and low liquidity
in the Ordinary Shares and with a focus on reducing the Company's cost base,
the Directors have conducted a review of the benefits and drawbacks to the
Company retaining the admission of its Ordinary Shares to trading on AIM. In
light of this, the Company has also obtained feedback from its Shareholders
and CULS Holders and believes the proposed Cancellation to be in the best
interests of the Company, its Shareholders and the CULS Holders as a whole.

 

In reaching this conclusion, the Directors have considered the following key
factors:

 

·    Cost of holding an AIM admission: The considerable cost associated
with maintaining the admission of the Ordinary Shares on AIM (such as
nominated adviser and broker fees, London Stock Exchange fees and the costs
associated with being a quoted company in having perceived higher levels of
corporate governance and audit scope) are, in the Directors' opinion,
disproportionately high, relative to the benefits.

 

·    Regulatory and time burden related to AIM admission: The Directors
further believe that the considerable amount of management time and regulatory
burden associated with maintaining the Company's admission to trading on AIM
are, in the Directors' opinion, disproportionate to the benefits to the
Company. In particular, as the Ordinary Shares are also admitted to trading on
the Official List of The International Stock Exchange ("TISE") this has
resulted in a duplication of the amount of management time and the regulatory
burden that is required. Accordingly, the Directors believe that the proposed
Cancellation is the prudent solution. The Cancellation would produce time
savings which could be better utilised for the benefit of the Company and
value creation for its shareholders. However, shareholders would continue to
benefit from the transparency resulting from the continued TISE admission
which is substantially similar to that associated with an admission to AIM.

 

·    Current challenges regarding liquidity: The Directors believe that
the current levels of liquidity in trading of the Ordinary Shares on AIM do
not, in itself, offer investors the opportunity to trade in meaningful volumes
or with the frequency afforded by an active market in addition to an admission
to TISE.

 

Following careful consideration of all relevant factors and in light of the
above, the Directors believe that it is in the best interests of the Company,
the Shareholders and the CULS Holders, taken as a whole, to seek the proposed
Cancellation at the earliest opportunity.

 

The Company intends to maintain its TISE listing following Cancellation to
trading in its Ordinary Shares on AIM. Therefore, shareholders in the Company
will continue to be able to effect transactions in the Company's Ordinary
Shares on TISE following Cancellation and the Company therefore believes that
it is not necessary to make arrangements for a liquidity mechanism such as a
matched bargain facility to assist Shareholders to trade in the Ordinary
Shares.

 

The CULS will also continue to be admitted to trading on the London Stock
Exchange's International Securities Market. As the CULS are no longer
convertible (as explained below) the Ordinary Shares are no longer required to
be admitted to AIM or another suitable market pursuant to the rules of the
International Securities Market.

 

3.   Background to and reasons for the Trust Deed Amendments

 

The CULS were issued in 2017 and 2018. The Maturity Date of the CULS in
accordance with the Trust Deed was 30 September 2024, on which the Company had
covenanted to repay the outstanding CULS at par value, plus accrued interest.
At a meeting of the CULS Holders held on 30 September 2024, the CULS Holders
approved the deferral of the full payment of the CULS redemption proceeds to
31 March 2025. Accordingly, the Company now has a £27.7 million payment
obligation to satisfy the full redemption amount of the Company's outstanding
CULS on 31 March 2025 (the "CULS Obligation").

 

Pursuant to the Trust Deed, the Maturity Date of 30 September 2024 was not
deferred or extended and has therefore now passed. This was the last date at
which holders of CULS were able to convert into Ordinary Shares and therefore
the CULS are no longer capable of being converted into Ordinary Shares.

 

As discussed in circulars issued by the Company dated 6 September 2024 and 14
February 2025, the Board had been confident that the Company would have
sufficient resources to satisfy the CULS Obligation, particularly in view of
the revenue generated by the Group's Delphos business. However, on 7 February
2025 the Company announced an update on its financial and trading position and
the challenges that it is facing. In particular, the new US Administration has
created a very challenging environment for Delphos.

 

The Company is therefore seeking approval from CULS Holders for the deferral
of the settlement date from 31 March 2025 to 31 December 2025 (the "Deferred
Settlement Date", as set out in the terms of CULS Resolution 2 below). The
Board is confident that the extension of this settlement deadline will allow
the Company sufficient time to refinance the CULS, raise equity finance and/or
generate sufficient cash reserves to make full repayment of the outstanding
CULS prior to 31 December 2025. The Company will make such payment as soon as
reasonably practicable.

 

In consideration of CULS Holders approving the proposed deferral of the full
payment of CULS redemption proceeds, the Company is offering an economic
benefit to CULS Holders. The interest rate applying to the outstanding CULS
will be increased from 6.0 per cent. (previously increased from 3.5 per cent.)
to 10.0 per cent. for the period from the 31 March 2025 to the Deferred
Settlement Date (the "Additional Interest"), such Additional Interest to be
rolled up and payable on the Deferred Settlement Date instead of being payable
quarterly.

 

The amendments to the Trust Deed are summarised in paragraph 5 below and are
set out in full in the text of CULS Resolution 2 set out in the CULS Notice at
the end of the Circular.

 

The Company will also be giving certain undertakings to CULS Holders in view
of the proposed Trust Deed Amendments which are summarised in paragraph 6
below.

 

The Board believes that the Proposals set out in the Circular are in the
interests of CULS Holders as they should ensure that the full amount due and
owing to the CULS Holders will still be paid in full, with an uplift in the
final amount due. The Board firmly believes that the payment can be made in
full by 31 December 2025 and is seeking CULS Holders' support while it is in
the process of refinancing negotiations and building the business of the
Company, so as not to endanger the prospects of the Company by liquidating
promising assets.

 

4.   Process for, and principal effects of, the Cancellation

 

The Directors are aware that certain Shareholders may be unable or unwilling
to hold Ordinary Shares in the event that the Cancellation is approved and
becomes effective. Such Shareholders should consider selling their Ordinary
Shares in the market prior to the Cancellation becoming effective.

 

Under the AIM Rules, the Company is required to give at least 20 clear
Business Days' notice of Cancellation. Additionally, the Cancellation will not
take effect until at least five clear Business Days have passed following the
passing of the Resolution at the EGM (which is conditional on the passing of
the Resolutions at the CULS Meeting). If the Resolutions are passed at the EGM
and CULS Meeting, the last day of trading in Ordinary Shares on AIM will be 7
April 2025 and the Cancellation will take effect at 7.00 a.m. on 8 April 2025.

 

The principal effects of the Cancellation will be that:

 

·    there will be no formal market mechanism enabling the Shareholders to
trade Ordinary Shares through AIM which may significantly reduce the liquidity
and marketability of the Ordinary Shares;

 

·    while the Ordinary Shares will remain freely transferrable and are
expected to remain listed on TISE, it is possible that the liquidity and
marketability of the Ordinary Shares will, in the future, be even more
constrained than at present and the value of such Ordinary Shares may be
adversely affected as a consequence;

 

·    the regulatory and financial reporting obligations, as well as
disclosure and corporate governance requirements applicable to companies whose
shares are admitted to trading on AIM, would no longer apply;

 

·    Shareholders will no longer be afforded the protections given by the
AIM Rules, such as the requirement to be notified of certain events and the
separate requirement to seek approval from Shareholders for certain other
corporate events;

 

·    the Cancellation may have taxation or other commercial consequences
for Shareholders. Shareholders who are in any doubt about their tax position
should consult their own professional independent tax adviser;

 

·    Singer Capital Markets would cease to be the Company's Nominated
Adviser and Broker; and

 

·    in the absence of a quote on AIM, it may be more difficult for
Shareholders to determine the market value of their investment in the Company
at any given time.

 

Shareholders should note that the Takeover Code will continue to apply to the
Company following the Cancellation due to the listing of the Ordinary Shares
on TISE. The Company will also continue to be bound by the Articles (which
require Shareholder approval for certain matters) following the Cancellation.

 

The above considerations are not exhaustive, and Shareholders should seek
their own independent advice when assessing the likely impact of the
Cancellation on them.

 

The Company currently intends to continue to provide certain facilities and
services to Shareholders that they currently enjoy as shareholders of an AIM
company. The Company will:

 

·    continue to maintain the listing of the Ordinary Shares on TISE;

 

·    continue to communicate information about the Company (including
annual accounts) to its Shareholders;

 

·    continue to hold annual general meetings;

 

·    continue, for at least 12 months following the Cancellation, to
maintain its corporate website https://www.apqglobal.com
(https://www.apqglobal.com) and to post updates on the website from time to
time, although Shareholders should be aware that there will be no obligation
on the Company to include all of the information required under the AIM Rules
or to update the website as required by the AIM Rules;

 

·    continue to maintain the Company's CREST facility; and

 

·    continue to maintain a Board structure with at least one independent
non-executive director.

 

Whether or not Shareholders seek to sell their Ordinary Shares in light of the
proposed Cancellation is a matter for individual Shareholders and will depend
on their personal circumstances. The Directors make no recommendation in this
respect and any Shareholders who are in any doubt as to what they should do
are advised to seek their own independent advice from a professional.

 

5.   Proposed Amendments to the Trust Deed

 

If CULS Resolution 2 to be proposed at the CULS Meeting is passed, the Trust
Deed will be amended as follows.

 

·    The payment obligations of the Company on 31 March 2025 in respect of
the redemption of the CULS will be deferred. At present the Company is
required to pay aggregate redemption proceeds, together with accrued interest,
to the Trustee on 31 March 2025, for onward payment to the CULS Holders. The
Company proposes a Deferred Settlement Date (being the date on which such
proceeds will be paid to the Trustee) of no later than 31 December 2025. The
Deferred Settlement Date may be any date from 31 March 2025 to 31 December
2025 inclusive, at the discretion of the Company. The Company will give
advance notice of the intended Deferred Settlement Date to CULS Holders.

 

·    The interest rate applying to the outstanding CULS will be increased
from 6.0 per cent. to 10.0 per cent. for the period from 31 March 2025 to, but
excluding, the Deferred Settlement Date.

 

·    The Additional Interest will be payable on the Deferred Settlement
Date instead of being payable quarterly.

 

·    The redemption premium introduced in September 2024 will cease with
effect from 31 March 2025, although accrued entitlements to the redemption
premium will be paid on the Deferred Settlement Date.

 

6.   Company's undertakings to CULS Holders

 

Conditional on the approval of the Resolutions at the Extraordinary General
Meeting and the CULS Meeting, the Company hereby undertakes to the CULS
Holders that, prior to the Deferred Settlement Date:

 

·    The Company shall not make any further investments beyond what is
reasonably required to support the existing operations of the Group, as
determined by the Board.

 

·    The Company shall not incur any Financial Indebtedness which ranks
prior to the CULS unless such Financial Indebtedness is incurred for the
purpose of satisfying the CULS Obligation and/or paying the Additional
Interest.

 

·    The Company shall apply any cash reserves in excess of a rolling
amount of US$5,000,000 (to be held for working capital purposes) towards the
reduction of the CULS liability. This may be by any, or a combination, of ad
hoc purchases of CULS, one or more tender offers for CULS or redeeming the
CULS, as determined by the Board.

 

7.   Process for Cancellation

 

Under the AIM Rules, it is a requirement that the Cancellation must be
approved by not less than 75 per cent. of votes cast by Shareholders at an
Extraordinary General Meeting. Accordingly, the EGM Notice contains a special
resolution to approve the Cancellation.

 

Furthermore, Rule 41 of the AIM Rules requires any AIM company that wishes the
London Stock Exchange to cancel the admission of its shares to trading on AIM
to notify shareholders and to separately inform the London Stock Exchange of
its preferred cancellation date at least 20 Business Days prior to such date.
In accordance with AIM Rule 41, the Directors have notified the London Stock
Exchange of the Company's intention, subject to the Resolutions being passed
at the Extraordinary General Meeting and the CULS Meeting, to cancel the
Company's admission of the Ordinary Shares to trading on AIM on 8 April 2025.
If the Cancellation becomes effective, Singer Capital Markets will cease to be
nominated adviser of the Company and the Company will no longer be required to
comply with the AIM Rules.

 

8.   Extraordinary General Meeting

 

In order to implement the Cancellation, the Board requires Shareholders to
approve the Resolution to be proposed at the EGM which has been convened for
10.30 a.m. on 31 March 2025, to be held at the Company's registered office,
2nd Floor, Lefebvre Place, Lefebvre Street, St Peter Port, Guernsey, GY1 2JP
Channel Islands. The EGM Notice is set out at the end of the Circular.

 

The majority required for the passing of the EGM Resolution, which is
conditional on the passing of CULS Resolution 1 and CULS Resolution 2, is not
less than 75 per cent. of the persons voting in person or by proxy upon a show
of hands or, if a poll is duly demanded, not less than 75 per cent. of the
votes given on such poll, where every Shareholder who is present in person or
by proxy has one vote for each Ordinary Share held.

 

The quorum for the Extraordinary General Meeting is one or more members
present in person or by proxy and holding five per cent. or more of the voting
rights available at such meeting.

 

9.   Action to be taken by Shareholders

 

You will find enclosed with the Circular a Form of Proxy for use at the
Extraordinary General Meeting. Regardless of whether you intend to attend the
Extraordinary General Meeting in person, it is important that you complete and
sign the enclosed Form of Proxy in accordance with the instructions printed on
it and return it to the Company Secretary, Beauvoir Limited, either by email
at richard.bray@beauvoirgroup.com or by registered post to Beauvoir Limited,
Attention to: Richard Bray, 2nd Floor, Lefebvre Place, Lefebvre Street, St
Peter Port, Guernsey, GY1 2JP, Channel Islands as soon as possible and, in any
event, so as to be received not later than 10.30 a.m. on 27 March 2025.

The completion and return of a Form of Proxy will not preclude you from
attending the Extraordinary General Meeting and voting in person if you wish
to do so.

 

10. Meeting of the CULS Holders

 

In order to implement amendments to the Trust Deed, the Board requires CULS
Holders to approve the Resolution to be proposed at the Meeting of the CULS
Holders which has been convened for 10.35 a.m. on 31 March 2025 (or as soon
thereafter as the Extraordinary General Meeting shall have concluded or been
adjourned), to be held at the Company's registered office, 2nd Floor, Lefebvre
Place, Lefebvre Street, St Peter Port, Guernsey, GY1 2JP Channel Islands. The
Notice of the Meeting is set out at the end of the Circular.

 

The majority required for the passing of CULS Resolution 1, which is
conditional on the passing of CULS Resolution 2 and the EGM Resolution, is not
less than 75 per cent. of the persons voting in person or by proxy upon a show
of hands or, if a poll is duly demanded, not less than 75 per cent. of the
votes given on such poll, where every CULS Holder who is present in person or
by proxy has one vote in respect of each £5,000 in nominal amount of CULS
held.

 

The majority required for the passing of CULS Resolution 2, which is
conditional on the passing of CULS Resolution 1 and the EGM Resolution, is not
less than 75 per cent. of the persons voting in person or by proxy upon a show
of hands or, if a poll is duly demanded, not less than 75 per cent. of the
votes given on such poll, where every CULS Holder who is present in person or
by proxy has one vote in respect of each £5,000 in nominal amount of CULS
held.

 

The quorum for the Meeting is CULS Holders present in person or by proxy or
(in the case of a CULS Holder which is a corporation) by its duly authorised
representative and holding or representing in the aggregate a clear majority
in nominal amount of the CULS for the time being outstanding.

 

EACH OF THE RESOLUTIONS ARE INTER-CONDITIONAL. IF ANY OF THE RESOLUTIONS ARE
NOT PASSED, NONE OF THE PROPOSALS WILL BE IMPLEMENTED.

 

11. Action to be taken by CULS Holders

 

You will find enclosed with the Circular a Form of Proxy for use at the
Meeting. Regardless of whether you intend to attend the Meeting in person, it
is important that you complete and sign the enclosed Form of Proxy in
accordance with the instructions printed on it and return it to the Company
Secretary, Beauvoir Limited, either by email at richard.bray@beauvoirgroup.com
or by registered post to Beauvoir Limited, Attention to: Richard Bray, 2nd
Floor, Lefebvre Place, Lefebvre Street, St Peter Port, Guernsey, GY1 2JP,
Channel Islands as soon as possible and, in any event, so as to be received
not later than 10.35 a.m. on 28 March 2025.

 

The completion and return of a Form of Proxy will not preclude you from
attending the CULS Meeting and voting in person if you wish to do so.

 

12. Recommendation

 

The Board believes that approval of the Resolutions relating to the
Cancellation and Trust Deed Amendments is in the best interests of the
Company, the Shareholders and the CULS Holders and unanimously recommends that
you vote in favour of the Resolutions to be proposed at the Extraordinary
General Meeting and CULS Meeting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKABDNBKDKNK